1-8 of 8
Sylvia Bellucci
Close
Sort by
Journal Articles

Complete Hematological, Molecular and Histological Remissions without Cytoreductive Treatment Lasting After Pegylated-Interferon α-2a (peg-IFNα-2a) Therapy in Polycythemia Vera (PV): Long Term Results of a Phase 2 Trial

Pascal Turlure, MD, Nathalie Cambier, MD, Murielle Roussel, Sylvia Bellucci, MD, PhD, Jean-Marc Zini, MD, PhD, Jean-Didier Rain, MD, Philippe Rousselot, MD, PhD, William Vainchenker, MD, PhD, Lina Abdelkader, Kamel Ghomari, Jean-Luc Dutel, Yasmine Chait, Sylvie Chevret, Christine Chomienne, MD, PhD, Bruno Cassinat, PharmD, Jean-Jacques Kiladjian, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 280.
https://doi.org/10.1182/blood.V118.21.280.280
Published: 2011
Journal Articles

The JAK2 46/1 haplotype in splanchnic vein thrombosis

Eirini Kouroupi, Jean-Jacques Kiladjian, Christine Chomienne, Christine Dosquet, Sylvia Bellucci, Dominique Valla, Bruno Cassinat
Journal: Blood
Blood (2011) 117 (21): 5777–5778.
https://doi.org/10.1182/blood-2011-03-343657
Published: 2011
Journal Articles

Lack of Association Between the 46/1 JAK2 Haplotype and the Presence of JAK2V617F Mutation In Splanchnic Vein Thrombosis Patients

Eirini G Kouroupi, MD, Bruno Cassinat, PharmD, Aurelie Plessier, MD, Sylvia Bellucci, MD, Christine Chomienne, MD, PhD, Bernard Granchamp, MD, PhD, Dominique Valla, MD, PhD, Jean-Jacques Kiladjian, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 4120.
https://doi.org/10.1182/blood.V116.21.4120.4120
Published: 2010
Journal Articles

Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera

Clinical Trials & Observations
Jean-Jacques Kiladjian, Bruno Cassinat, Sylvie Chevret, Pascal Turlure, Nathalie Cambier, Murielle Roussel, Sylvia Bellucci, Bernard Grandchamp, Christine Chomienne, Pierre Fenaux
Journal: Blood
Blood (2008) 112 (8): 3065–3072.
https://doi.org/10.1182/blood-2008-03-143537
Published: 2008
Journal Articles

Peg IFNα-2a in Polycythemia Vera (PV). Results of a Phase 2 Study by the French “PV-NORD” Group.

Jean-Jacques Kiladjian, MD, Bruno Cassinat, MD, Pascal Turlure, MD, Nathalie Cambier, MD, Sylvia Bellucci, MD,PhD, Murielle Roussel, MD, Marie-José Grange, MD, Bernard Grandchamp, MD,PhD, Jean-Didier Rain, MD,PhD, Christine Chomienne, MD,PhD, Pierre Fenaux, MD,PhD
Journal: Blood
Blood (2006) 108 (11): 670.
https://doi.org/10.1182/blood.V108.11.670.670
Published: 2006
Journal Articles

High molecular response rate of polycythemia vera patients treated with pegylated interferon α–2a

Clinical Trials & Observations Brief Report
Jean-Jacques Kiladjian, Bruno Cassinat, Pascal Turlure, Nathalie Cambier, Murielle Roussel, Sylvia Bellucci, Marie-Laurence Menot, Gerald Massonnet, Jean-Luc Dutel, Kamel Ghomari, Philippe Rousselot, Marie-Jose Grange, Yasmina Chait, William Vainchenker, Nathalie Parquet, Lina Abdelkader-Aljassem, Jean-François Bernard, Jean-Didier Rain, Sylvie Chevret, Christine Chomienne, Pierre Fenaux
Journal: Blood
Blood (2006) 108 (6): 2037–2040.
https://doi.org/10.1182/blood-2006-03-009860
Published: 2006
Journal Articles

PVN1: A Phase 2 Study of Pegylated Interferon-α2a in Polycythemia Vera (PV) by the “PV-Nord” Group. Preliminary Report of Efficacy and Safety.

Jean-Jacques Kiladjian, MD, Bruno Cassinat, MD, Pascal Turlure, MD, Sylvia Bellucci, MD, Nathalie Cambier, MD, Murielle Roussel, MD, Marie-José Grange, MD, Jean-Didier Rain, MD, Christine Chomienne, MD, Pierre Fenaux, MD
Journal: Blood
Blood (2005) 106 (11): 4940.
https://doi.org/10.1182/blood.V106.11.4940.4940
Published: 2005
Journal Articles

Severe Proximal Deep Vein Thrombosis in a Glanzmann Thrombasthenia Variant Successfully Treated With a Low Molecular Weight Heparin

Yves Gruel, Gérard Pacouret, Sylvia Bellucci, Jacques Caen
Journal: Blood
Blood (1997) 90 (2): 888–889.
https://doi.org/10.1182/blood.V90.2.888
Published: 1997